Healthcare -
Biotechnology - NASDAQ - US
$ 8.75
1.74 %
$ 602 M
Market Cap
-3.16
P/E
ARVN - CASH FROM INVESTING ACTIVITIES
Cash from Investing Activities ARVN - Arvinas, Inc.
34.7 M
LAST VALUE
-62.20%
2 YEAR CAGR
18.86%
5 YEAR CAGR
0.00%
10 YEAR CAGR